亚太药业 (002370.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(亚太药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
关 闭
完整财报对比
2019年一季报2018年年报2018年三季报2018年中报2018年一季报2017年年报2017年三季报2017年中报2017年一季报
主要指标:
 营业收入(元) 366,129,207.791,309,709,237.78958,708,104.41662,249,365.61319,164,772.951,082,951,050.52824,479,011.89494,646,766.92246,492,170.82
 营业利润(元) 71,379,842.53241,398,801.32203,361,376.33159,402,838.1378,750,870.79237,157,418.52171,357,911.12113,578,796.3256,003,546.04
 利润总额(元) 71,383,309.50241,426,801.32203,394,592.52159,435,511.3278,813,479.89237,152,693.58177,780,445.61119,353,927.9855,969,140.74
 净利润(元) 56,701,103.04209,372,976.66168,083,376.92132,769,116.0966,290,157.66203,042,147.84151,327,522.18101,557,477.9547,201,280.52
 归属于母公司股东的净利润(元) 56,792,536.07207,785,781.83166,570,989.32131,349,900.1965,492,888.74202,152,119.51150,546,058.21101,607,324.8146,764,741.57
盈利能力:
 销售毛利率(%) 38.5143.9246.2547.2749.0044.5541.8241.0438.53
 销售净利率(%) 15.4915.9917.5320.0520.7718.7518.3520.5319.15
 净资产收益率(%) 2.278.536.975.592.81----
 总资产报酬率ROA(%) 2.308.387.305.672.92----
 投入资本回报率ROIC(%) 1.907.956.335.122.688.766.604.512.11
营运能力:
 存货周转率(次) 1.325.144.292.781.45----
 应收账款周转率(次) 0.873.902.952.181.07----
 总资产周转率(次) 0.110.430.330.230.12----
偿债能力:
 资产负债率(%) 27.9823.4523.3924.1218.0113.4710.4011.5311.91
 股东权益比率(%) 71.6976.1976.2575.5181.6186.1689.2188.1087.71
 已获利息倍数(倍) 18.3121.9022.8434.8145.88-42.82-35.48-35.84-28.23
 流动比率 3.784.315.234.996.094.735.064.594.39
 速动比率 2.883.234.014.094.833.914.263.833.67
发展能力:
 营业收入增长率(%) 14.7120.9416.2833.8829.4825.5139.0315.8019.60
 营业利润增长率(%) -9.361.7914.3039.5240.6275.1385.5458.8791.10
 税后利润增长率(%) -13.282.7910.6429.2740.0561.3576.0158.8093.23
 净资产增长率(%) 5.976.507.077.828.627.947.54173.01176.41
 总资产增长率(%) 20.6320.4225.2625.8016.7310.82-2.9432.6130.23

前瞻产业研究院